Georgios Ioannidis, Head of the Oncology Department at Nicosia General Hospital, shared a post on LinkedIn about a paper he co-authored with colleagues published in BMC Cancer:
“Patient satisfaction is an essential outcome of patient-centered care and reflects how well healthcare delivery responds to patients’ needs and expectations.
The EORTC – European Organisation for Research and Treatment of Cancer Quality of Life Group has developed a patient satisfaction core questionnaire (PATSAT-C33) to be used in any hospital cancer care setting and an outpatient satisfaction module (OUT-PATSAT7) to address specific aspects of ambulatory cancer care.
The Oncology Department of Nicosia General Hospital is proud to have contributed to the finalization of these two PROMS through an international multi-center validation study, the results of which are now published in BMC Cancer. Many thanks to Prof. Anne Brédart (Institut Curie) and all the participating centres for their fruitful collaboration.”
Mieke Van Hemelrijck, Professor in Cancer Epidemiology at King’s College London, shared this post, adding:
“Another great EORTC – European Organisation for Research and Treatment of Cancer collaboration for TOUR: Transforming cancer Outcomes through Research! Let’s make sure that this questionnaire now gets implemented in clinical practice – developing a strategy for improvements in patient experiences.”
Title: Phase IV international prospective validation of the EORTC patient satisfaction core questionnaire (EORTC PATSAT-C33) and outpatient module (EORTC OUT-PATSAT7)
Authors: Anne Brédart, Jean-Luc Kop, Omar Shamieh, Louis Fox, Waleed Alrjoub, Thierry Conroy, Nazim Serdar Turhal, I. Juan Arraras, Renée Bultijnck, Armélie Harle, Mieke Van Hemelrijck, Eleonora Pinto, Eric J. U. Roth, Georgios Ioannidis, Anna Costantini, Tara Chalk, Teresa Young, Gudrun Rohde, Hiroto Ishiki, Yuichiro Kikawa, Heike Schmidt, Vassilios Vasiliou, Stephanie Shayler, Frédéric Marchal, Anota Amélie, Jens Lehmann, and EORTC Quality of Life Group
You can read the Full Article in BMC Cancer.
More posts featuring Mieke Van Hemelrijck.
